James Min, MD
About James Min, MD
James Min, MD, is the Founder and Chief Executive Officer of Cleerly, Inc., with a distinguished career in cardiology and medical research.
Current Position at Cleerly, Inc.
James Min, MD, is the Founder and Chief Executive Officer of Cleerly, Inc., a company based in the Greater New York City Area. In this role, he currently leads the organization in developing and advancing innovative solutions for cardiovascular health.
Academic Roles at Weill Cornell Medical College and NewYork-Presbyterian Hospital
From 2013 to 2019, James Min served as a Professor of Radiology and Medicine (Cardiology) at Weill Cornell Medical College and the NewYork-Presbyterian Hospital in the Greater New York City Area. During this six-year period, he contributed to academic research and medical education in the field of cardiology.
Leadership at Dalio Institute of Cardiovascular Imaging
James Min was the Director of the Dalio Institute of Cardiovascular Imaging from 2013 to 2019 in Greater New York City Area. In this capacity, he led advanced imaging research and initiatives to enhance the understanding and treatment of cardiovascular diseases.
Prior Academic Experience
Before his tenure in New York, James Min worked as an Associate Professor of Medicine (Cardiology) at Cedars Sinai Medical Center and the David Geffen UCLA School of Medicine from 2011 to 2013 in Greater Los Angeles Area. Additionally, he served as an Assistant Professor of Medicine (Cardiology) at Weill Cornell Medicine from 2005 to 2011.
Educational Background
James Min completed his Doctor of Medicine (M.D.) at Temple University - Lewis Katz School of Medicine. He further specialized in Internal Medicine and Cardiovascular Medicine at the University of Chicago Pritzker School of Medicine, where he also earned his Bachelor's Degree.
Contributions to Cardiovascular Research
James Min has published over 500 peer-reviewed manuscripts, supported by grants from the National Institutes of Health and the Dalio Foundation. He has served as Principal Investigator in numerous landmark multicenter clinical trials, directed a state-of-the-art core laboratory for coronary computed tomography, and has been involved in developing a four-stage system for measuring coronary artery disease burden.
Accolades and Recognitions
James Min has been honored by Business Insider's inaugural AI 100 list and featured in the AARP Bulletin cover story on heart disease. Nasdaq has interviewed him as one of their '18 Brilliant Minds in Healthcare'. He holds the titles of Fellow of the American College of Cardiology, Fellow of the European Society of Cardiology, and Fellow of the Society of Cardiovascular Computed Tomography.